The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Morning Seminar

MS3-12

The role of Immune checkpoint inhibitor in hematological malignancies

Sun. Oct 14, 2018 7:30 AM - 8:15 AM No.12 (Osaka International Convention Center, 10F 1006-7)

Chair: Akihiro Tomita (Division of Hematology, Fujita Health University School of Medicine)

Sponsors: MSD K.K./TAIHO PHARMACEUTICAL CO., LTD.

[MS3-12] The role of Immune checkpoint inhibitor in hematological malignancies

Koji Kato (Department of Hematology, Oncology and Cardiovascular medicine，Kyushu University Hospital)